JCPyV miR-J1-5p in Urine of Natalizumab-Treated Multiple Sclerosis Patients
Sign Up to like & getrecommendations! Published in 2021 at "Viruses"
DOI: 10.3390/v13030468
Abstract: The use of Natalizumab in Multiple Sclerosis (MS) can cause the reactivation of the polyomavirus JC (JCPyV); this may result in the development of progressive multifocal leukoencephalopathy (PML), a rare and usually lethal disease. JCPyV… read more here.
Keywords: natalizumab treated; jcpyv infection; jcpyv mir; multiple sclerosis ... See more keywords